Comparison
NMN vs Fisetin
NMN
Nicotinamide mononucleotide — NAD+ precursor. Studied for cellular aging and metabolic health.
Fisetin
Flavonoid found in strawberries. Senolytic — selectively clears senescent cells. Promising longevity intervention.
| Field | NMN | Fisetin |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 250–1000mg | 100–500mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEB |
| Safety | ●●●●● | ●●●●○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 600 | 1700 |
The comparison in plain English
Auto-generated from dataNMN and Fisetin are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. Fisetin Flavonoid found in strawberries.
Bottom line
NMN (evidence B, safety 5/5) matches the evidence base of Fisetin (evidence B, safety 4/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose NMN if
NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.
Choose Fisetin if
Fisetin is the better fit when your goal aligns with its mechanism (Senolytic activity — selectively induces apoptosis in senescent cells (cells that have stopped dividing but remain metabolically active and inflammatory)) and the dose range (100–500mg) suits your protocol. Half-life is —h.